Company Filing History:
Years Active: 2010
Title: Janja Smid: Innovator in Pharmaceutical Chemistry
Introduction
Janja Smid is a notable inventor based in Novo mesto, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of ACE inhibitors. His work has implications for the treatment of various medical conditions, showcasing the importance of innovation in healthcare.
Latest Patents
Janja Smid holds a patent for a process for the preparation of perindopril and its salts. This invention relates to a method for synthesizing the ACE inhibitor (2S,3aS,7aS)-1-((2S)-2-(((1S)-1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-1H-indol-2-carboxylic acid, along with pharmaceutically acceptable salts and useful intermediates in the process. This patent highlights his expertise in creating effective pharmaceutical compounds.
Career Highlights
Janja Smid is associated with Les Laboratoires Servier, a prominent pharmaceutical company. His role there has allowed him to contribute to the development of innovative treatments that can improve patient outcomes. His dedication to research and development is evident in his patent work and ongoing projects.
Collaborations
Janja collaborates with talented professionals in his field, including Marjo Merslavic and Zdenka Tomsic. These collaborations enhance the research environment and foster innovation within the pharmaceutical industry.
Conclusion
Janja Smid's contributions to pharmaceutical chemistry, particularly through his patent for perindopril, demonstrate the vital role of inventors in advancing medical science. His work at Les Laboratoires Servier and collaborations with colleagues further emphasize the importance of teamwork in driving innovation.